These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12719508)

  • 1. Psychotropic medication expenditures for community-dwelling elderly persons.
    Aparasu R; Mort J; Brandt H
    Psychiatr Serv; 2003 May; 54(5):739-42. PubMed ID: 12719508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expenditures for psychotropic medications in the United States in 1985.
    Zorc JJ; Larson DB; Lyons JS; Beardsley RS
    Am J Psychiatry; 1991 May; 148(5):644-7. PubMed ID: 2018168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
    Martin A; Leslie D
    Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic prescription use by community-dwelling elderly in the United States.
    Aparasu RR; Mort JR; Brandt H
    J Am Geriatr Soc; 2003 May; 51(5):671-7. PubMed ID: 12752843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid expenditures on psychotropic medications for children in the child welfare system.
    Raghavan R; Brown DS; Thompson H; Ettner SL; Clements LM; Key W
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):182-9. PubMed ID: 22537361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from trends in psychotropic drug expenditures in a canadian province.
    Dewa CS; Goering P
    Psychiatr Serv; 2001 Sep; 52(9):1245-7. PubMed ID: 11533401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly.
    Aparasu RR; Mort JR
    Am J Geriatr Pharmacother; 2004 Jun; 2(2):102-11. PubMed ID: 15555486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
    Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
    Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.
    Jensen PS; Bhatara VS; Vitiello B; Hoagwood K; Feil M; Burke LB
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):557-65. PubMed ID: 10230187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of the costs of psychotropic medications: an update.
    Jurman RJ; Davis JM
    Psychiatr Med; 1991; 9(2):349-59. PubMed ID: 1677482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
    Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
    Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009.
    Wu CH; Wang CC; Katz AJ; Farley J
    J Anxiety Disord; 2013 Mar; 27(2):163-70. PubMed ID: 23428605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.
    Ong MK; Xu H; Zhang L; Azocar F; Ettner SL
    J Am Geriatr Soc; 2012 Jul; 60(7):1292-7. PubMed ID: 22725849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.